Grantham, Mayo, Van Otterloo & Co (GMO)
SNPS icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Synopsys SNPS Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio SNPS Stock Details SNPS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$429M Buy
961,706
+51,573
+6% +$24.3M 0.97% 31
2026
Q1 		$361M Buy
+910,133
New +$411M 0.92% 31
2025
Q2 		– Sell
-6,610
Closed -$2.83M – 678
2025
Q1 		$2.83M Buy
+6,610
New +$3.21M 0.01% 354
2024
Q3 		– Sell
-344
Closed -$205K – 595
2024
Q2 		$205K Sell
344
-3,032
-90% -$1.71M ﹤0.01% 510
2024
Q1 		$1.93M Sell
3,376
-3,266
-49% -$1.8M 0.01% 365
2023
Q4 		$3.42M Sell
6,642
-10,053
-60% -$5.14M 0.02% 312
2023
Q3 		$7.66M Sell
16,695
-637
-4% -$285K 0.04% 284
2023
Q2 		$7.55M Sell
17,332
-760
-4% -$306K 0.03% 291
2023
Q1 		$6.99M Sell
18,092
-12,700
-41% -$4.54M 0.04% 290
2022
Q4 		$9.83M Sell
30,792
-17,200
-36% -$5.38M 0.05% 234
2022
Q3 		$14.7M Sell
47,992
-7,000
-13% -$2.37M 0.08% 208
2022
Q2 		$16.7M Buy
54,992
+5,904
+12% +$1.78M 0.09% 204
2022
Q1 		$16.4M Buy
49,088
+16,277
+50% +$5.08M 0.08% 204
2021
Q4 		$12.1M Sell
32,811
-370
-1% -$125K 0.06% 223
2021
Q3 		$9.94M Sell
33,181
-19,701
-37% -$5.98M 0.05% 247
2021
Q2 		$14.6M Sell
52,882
-8,318
-14% -$2.11M 0.07% 202
2021
Q1 		$15.2M Buy
61,200
+38,774
+173% +$9.85M 0.08% 185
2020
Q4 		$5.81M Sell
22,426
-16,655
-43% -$3.84M 0.04% 274
2020
Q3 		$8.36M Sell
39,081
-346
-0.9% -$70.4K 0.06% 174
2020
Q2 		$7.69M Sell
39,427
-17,192
-30% -$2.84M 0.06% 180
2020
Q1 		$7.29M Sell
56,619
-300
-0.5% -$42.7K 0.06% 179
2019
Q4 		$7.92M Sell
56,919
-9,800
-15% -$1.34M 0.05% 228
2019
Q3 		$9.16M Sell
66,719
-22,300
-25% -$3.02M 0.06% 196
2019
Q2 		$11.5M Sell
89,019
-4,900
-5% -$589K 0.08% 171
2019
Q1 		$10.8M Sell
93,919
-3,600
-4% -$357K 0.08% 173
2018
Q4 		$8.21M Hold
97,519
– – 0.07% 154
2018
Q3 		$9.62M Sell
97,519
-19,300
-17% -$1.84M 0.07% 156
2018
Q2 		$10M Sell
116,819
-37,681
-24% -$3.28M 0.07% 157
2018
Q1 		$12.9M Sell
154,500
-27,800
-15% -$2.44M 0.08% 138
2017
Q4 		$15.5M Buy
182,300
+3,400
+2% +$294K 0.09% 130
2017
Q3 		$14.4M Buy
178,900
+28,100
+19% +$2.18M 0.08% 139
2017
Q2 		$11M Buy
150,800
+117,200
+349% +$8.62M 0.06% 176
2017
Q1 		$2.42M Buy
+33,600
New +$2.25M 0.01% 305
2014
Q4 		– Sell
-41,100
Closed -$1.63M – 468
2014
Q3 		$1.63M Sell
41,100
-9,700
-19% -$385K ﹤0.01% 364
2014
Q2 		$1.97M Sell
50,800
-5,500
-10% -$210K 0.01% 364
2014
Q1 		$2.16M Sell
56,300
-1,899
-3% -$76.2K 0.01% 409
2013
Q4 		$2.36M Buy
58,199
+3,794
+7% +$142K 0.01% 387
2013
Q3 		$2.05M Buy
54,405
+7,200
+15% +$267K 0.01% 405
2013
Q2 		$1.69M Buy
+47,205
New +$1.68M ﹤0.01% 410

Other funds holding SNPS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NC
Nvidia Corp Santa Clara, California $63.4B AUM 136.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s SNPS Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Synopsys (SNPS) stake by 5.7% in Q2 2026, buying an estimated $24.3M and bringing the position to 961,706 shares worth $429M. The position accounts for 0.97% of the portfolio, ranked #31.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in SNPS in Q2 2013 and has held it in 39 quarters since. 1,444 funds tracked by Wall St. Rank hold SNPS as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 961,706 shares of Synopsys worth $429M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 51,573 Synopsys shares in Q2 2026, an estimated $24.3M.
  • Synopsys made up 0.97% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #31 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Synopsys in Q2 2013 and has held it in 39 quarters since.
  • 1,444 funds tracked by Wall St. Rank held Synopsys as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.